🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of human u...
Status
Unknown
Location
The Fifth Affiliated Hospital Immunotherapy center
Start Date
2015-03
Trial ID
NCT02283879
Treatments Being Tested
This is an open-label, single-arm, dose-escalating study to evaluate the sa...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12-01
Trial ID
NCT05162326
Treatments Being Tested
This study tests a new nasal spray for adults (18-65 years) with chronic si...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-01
Trial ID
NCT07635459
The goal of this clinical trial is to assess the safety of intracochlear ap...
Status
Active Not Recruiting
Location
Hannover Medical School, Dept. of Otorhinolaryngology
Start Date
2024-11-18
Trial ID
NCT06545175
Treatments Being Tested
To evaluate the safety and initial effectiveness of human umbilical cord me...
Status
Recruiting
Location
Shanghai Shanghai East Hospital, Tongji University School of Medicine
Start Date
2024-03-01
Trial ID
NCT06610773
Treatments Being Tested
This is a phase 1, randomized, placebo-controlled, double-blind, single-dos...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12-01
Trial ID
NCT03828344
Treatments Being Tested
To evaluate the safety and tolerability of IxCellhUC-MSC-S as a single intr...
Status
Completed
Location
Xuanwu Hospital of Capital Medical University
Start Date
2023-04-10
Trial ID
NCT05697718
Treatments Being Tested
This study tests a new nasal spray for adults (18-65 years) with chronic rh...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-01
Trial ID
NCT07635433
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled, dose-e...
Status
Recruiting
Location
Xuanwu Hospital ,Capital Medical University
Start Date
2024-12-01
Trial ID
NCT06598202
This phase 1 study is to evaluate the safety and tolerability of YB-1113 ad...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12-09
Trial ID
NCT05494723
Treatments Being Tested